Wednesday, June 10, 2026

Intelligence Β· INN directory

Pharmaceutical Drugs

Regulatory status, brand names, and pipeline context for BD, medical affairs, and competitive intelligence teams.

Drugs indexed 4,797
Companies 1,769
Pipeline programs 20,548

Quick answer

NovaPharmaNews tracks 4,797 pharmaceutical drugs by INN (International Nonproprietary Name), with US FDA approval status, brand names, originators, routes of administration, and links to pipeline programs and patents. Search by generic name or browse A–Z for competitive intelligence and medical affairs reference.

Showing page 105 of 200 Β· By data quality, then INN

  1. sunvozertinib

    ZEGFROVY

    ORAL FDA: approved Β· NMPA: clinical trials

  2. suprofen

    PROFENAL

    OPHTHALMIC FDA: approved

  3. sutilains

    TRAVASE

    TOPICAL FDA: approved

  4. sutimlimab-jome

    ENJAYMO

    INJECTION FDA: approved

  5. suvorexant

    SUVOREXANT

    ORAL FDA: approved

  6. tacrine hydrochloride

    COGNEX

    ORAL FDA: approved

  7. tafamidis

    VYNDAMAX Pfizer Australia Pty Ltd

    ORAL FDA: approved Β· EMA: approved Β· TGA: approved

    N07XX08
  8. tafamidis meglumine

    VYNDAQEL INITIAL APPROVAL

    ORAL FDA: approved Β· PMDA: approved

  9. tafasitamab-cxix

    MONJUVI

    INTRAVENOUS FDA: approved

  10. tafenoquine succinate

    KRINTAFEL

    ORAL FDA: approved

  11. tafluprost

    ZIOPTAN

    OPHTHALMIC FDA: approved

  12. tagraxofusp-erzs

    ELZONRIS

    INJECTION FDA: approved

  13. talazoparib tosylate

    TALZENNA

    ORAL FDA: approved

  14. talbutal

    LOTUSATE

    ORAL FDA: approved

  15. talc

    TALC

    INTRAPLEURAL FDA: approved

  16. taletrectinib adipate

    IBTROZI

    ORAL FDA: approved

  17. taliglucerase alfa

    ELELYSO

    INTRAVENOUS FDA: approved Β· EMA: refused

    A16AB11
  18. talquetamab-tgvs

    TALVEY

    INJECTION FDA: approved

  19. tapentadol

    PALEXIA SR Seqirus (Australia) Pty Ltd

    ORAL FDA: approved Β· TGA: approved

  20. tapinarof

    VTAMA

    TOPICAL FDA: approved

  21. tarlatamab-dlle

    IMDELLTRA

    INJECTION FDA: approved

  22. tazemetostat hydrobromide

    TAZVERIK

    ORAL FDA: approved Β· PMDA: approved

  23. tbo-filgrastim

    GRANIX

    INJECTION FDA: approved

  24. tebentafusp-tebn

    KIMMTRAK

    INJECTION FDA: approved

Frequently asked questions

What is the NovaPharmaNews drugs directory?

It is a searchable index of 4,797 pharmaceutical active ingredients and their marketed profiles β€” INN, brand names, US regulatory status, manufacturers, and cross-links to clinical pipeline and patent records.

Where does drug approval data come from?

Profiles combine FDA Drugs@FDA and Orange Book references, ClinicalTrials.gov pipeline links, and editorial enrichment. See our data sources page for attribution and update cadence. This directory is for professional reference, not medical advice.

How do I find a drug by brand name?

Use the search box on this page β€” it matches both INN (generic name) and slug. Brand names appear on each drug row and on the full drug profile page, with links to the originator company when available.